Tamarack Advisers’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-29,100
Closed -$5.86M 50
2022
Q2
$5.86M Buy
+29,100
New +$6.2M 3.39% 13
2021
Q3
Sell
-1,164
Closed -$276K 57
2021
Q2
$276K Sell
1,164
-86,136
-99% -$19.6M 0.08% 43
2021
Q1
$19.1M Sell
87,300
-29,100
-25% -$5.84M 3.92% 9
2020
Q4
$20.4M Buy
116,400
+23,280
+25% +$4.02M 4.25% 7
2020
Q3
$15.1M Buy
93,120
+29,100
+45% +$4.61M 4.64% 8
2020
Q2
$9.14M Buy
+64,020
New +$8.86M 2.54% 19
2018
Q4
Sell
-186,240
Closed -$27.8M 27
2018
Q3
$27.8M Buy
186,240
+66,348
+55% +$10.1M 7.93% 3
2018
Q2
$18.5M Buy
119,892
+65,184
+119% +$9.84M 6.19% 5
2018
Q1
$7.6M Sell
54,708
-38,412
-41% -$5.64M 3.62% 12
2017
Q4
$12.8M Buy
93,120
+23,280
+33% +$3.08M 6.97% 4
2017
Q3
$9.06M Sell
69,840
-9,312
-12% -$1.24M 5.55% 8
2017
Q2
$10.5M Buy
79,152
+23,280
+42% +$2.85M 6.12% 4
2017
Q1
$6.89M Sell
55,872
-3,492
-6% -$413K 4.3% 11
2016
Q4
$6.55M Buy
+59,364
New +$6.59M 4.63% 11
2016
Q3
Sell
-87,300
Closed -$9.77M 41
2016
Q2
$9.77M Sell
87,300
-46,560
-35% -$5.01M 3.75% 14
2016
Q1
$13.5M Buy
+133,860
New +$12.8M 4.71% 12

Other funds holding LH

Tamarack Advisers's LH Position: Q3 2022 in Review

Tamarack Advisers sold out of Labcorp (LH) in Q3 2022, closing a stake of 29,100 shares — an estimated $5.86M sold.

Tamarack Advisers first reported a position in LH in Q1 2016 and held it in 16 quarters. The position peaked at $27.8M in Q3 2018. 937 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • Tamarack Advisers reported no remaining Labcorp position as of Q3 2022 after selling out during the quarter.
  • Tamarack Advisers sold 29,100 Labcorp shares in Q3 2022, an estimated $5.86M.
  • Tamarack Advisers first reported a position in Labcorp in Q1 2016 and held it in 16 quarters.
  • Tamarack Advisers's Labcorp position peaked at $27.8M in Q3 2018.
  • 937 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on Tamarack Advisers's 13F filing for Q3 2022, filed 15 Nov 2022.